Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
03/2012
03/20/2012US8137960 Bovine adeno-associated viral (BAAV) vector and uses thereof
03/20/2012US8137948 Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
03/20/2012US8137947 Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator
03/20/2012US8137663 Oncolytic virus therapy
03/20/2012CA2763795A1 Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof
03/20/2012CA2464268C Regulated nucleic acid expression system
03/20/2012CA2441292C Equine herpesvirus vaccine
03/20/2012CA2379564C Structural protein of adeno-associated virus with modified chromatographic properties, its production and use
03/20/2012CA2334857C Interferon inducing genetically engineered attenuated viruses
03/20/2012CA2278616C Adenoviruses having altered hexon proteins
03/15/2012WO2012033236A1 Mdck cell line adapted to serum-free culture and suspension culture, and method for preparing viruses for vaccine using cells thereof
03/15/2012WO2012031760A1 Parvovirus mutated structural proteins comprising cross - protective b - cell epitopes of a hpv l2 protein as well as products and methods relating thereto
03/15/2012WO2011138053A3 Modified rodent parvovirus capable of propagating and spreading through human gliomas
03/15/2012WO2011119716A3 Flavivirus host range mutations and uses thereof
03/15/2012US20120064604 Methods for enhancing infectivity of retroviruses
03/15/2012US20120064603 Selective access to cryopreserved samples
03/15/2012US20120064569 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
03/15/2012US20120064117 Tetravalent influenza vaccine and use thereof
03/15/2012US20120064113 Novel Attenuated Poliovirus
03/15/2012US20120064112 Recombinant newcastle disease viruses useful as vaccines or vaccine vectors
03/15/2012US20120064111 Attenuated vaccines for non-segmented negative sense rna viruses
03/15/2012US20120064085 ANTI-INFLUENZA M2e ANTIBODY
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/14/2012EP2428564A1 A hepatitis b virus mutation strain with resistance to adefovir dipivoxil and the uses thereof
03/14/2012EP2427547A1 Method for producing virus from cell culture involving homogenization
03/14/2012EP1332218B1 Differentiation-inducing substances
03/14/2012CN102373184A Avian influenza and infectious bronchitis hybrid virus-like particle as well as preparation method and application thereof
03/14/2012CN102373183A Mixed virus-like particle (VLP) of avian influenza and Newcastle disease, preparation method thereof and application thereof
03/14/2012CN102373182A Mixed virus-like particle (VLP) of avian influenza and infectious bursal disease, preparation method thereof and application thereof
03/14/2012CN102373181A Swine influenza virus-porcine reproductive and respiratory syndrome virus mixed virus-like particle, and its preparation method and use
03/14/2012CN102373180A Recombinant duck enteritis virus (DEV) vaccine strain for expressing avian influenza virus haemagglutinin (HA) gene and constructing method and application thereof
03/14/2012CN102373179A (Blue Parvovirus)-TA isolated strain, standard sample of virus VP1, VP2 and NS1 genes complete sequences and preparation method thereof
03/14/2012CN101732709B Method for preparing haemorrhagic fever vaccine by culturing primary cells in multilayer culture flask
03/13/2012US8133712 Inactivated chimeric vaccines and related methods of use
03/13/2012US8133498 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
03/13/2012US8133494 Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2
03/13/2012CA2567254C Tc-83-derived alphavirus vectors, particles and methods
03/13/2012CA2505942C West nile virus vaccine
03/13/2012CA2423038C Live vaccine and method of manufacture
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/13/2012CA2199049C Novel pesticidal proteins and strains
03/08/2012WO2012031137A2 Vesicular stomatitis viruses
03/08/2012WO2012029770A1 Composition for inducing pluripotent stem cell, and use thereof
03/08/2012WO2012028681A1 Stable production of lentiviral vectors
03/08/2012WO2012028680A1 Semi-stable production of lentiviral vectors
03/08/2012US20120058539 Method for orthopoxvirus production and purification
03/08/2012US20120058538 Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems
03/08/2012US20120058145 Method for producing virus from cell culture involving homogenization
03/08/2012US20120058141 Chimeric newcastle disease viruses and uses thereof
03/08/2012CA2847413A1 Vesicular stomatitis viruses
03/08/2012CA2809515A1 Composition for inducing pluripotent stem cell, and use thereof
03/08/2012CA2809453A1 Stable production of lentiviral vectors
03/08/2012CA2809447A1 Semi-stable production of lentiviral vectors
03/07/2012EP2426142A2 Modified vaccinia virus strains for use in a diagnostic and therapeutic method
03/07/2012EP2425848A2 Influenza immunogen and vaccine
03/07/2012EP2424980A1 Recombinant virus-like particles encoded by multi-gene vector
03/07/2012CN102368906A Methods for inactivating viruses
03/07/2012CN101935634B Clonal strain of cabbage looper cell line and application thereof
03/06/2012US8129144 Papilloma pseudovirus and preparation
03/06/2012US8128937 N protein mutants of porcine reproductive and respiratory syndrome virus
03/06/2012CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
03/01/2012WO2012025603A1 An epstein-barr-virus vaccine
03/01/2012WO2012025534A1 Crop protection agents containing insect-pathogenic viruses, in particular baculoviruses, and cellulose sulfate
03/01/2012US20120052554 Gene delivery system and method of use
03/01/2012US20120052093 Compositions and methods for preventing and treating uterine disease
03/01/2012US20120052060 Human Antibody Molecules For IL-13
03/01/2012US20120052048 Antibacterial phage, phage peptides and methods of use thereof
03/01/2012CA2808689A1 Plant protection product comprising insect-pathogenic viruses, in particular baculoviruses, and cellulose sulfate
02/2012
02/29/2012EP2423216A1 Replication competent hepatitis C virus and methods of use
02/29/2012EP2195021B1 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
02/29/2012EP1002091B1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
02/29/2012CN102363770A Recombinant baculovirus capable of expressing porcine circovirus type 2 Cap protein and somatostatin in fusion manner, and subunit vaccine thereof
02/29/2012CN102363769A Chicken Marek's disease Meq gene deleted vaccine strain, construction method thereof, and application thereof
02/29/2012CN102363751A Dengue virus (DENV)-like particle as well as preparation method and application thereof
02/29/2012CN101979514B Virus and vaccine of porcine reproductive and respiratory syndrome and preparation method of same
02/29/2012CN101942424B Coding gene of UDP (Uridine Diphosphate)-glucosyltransferase mutant and application thereof
02/29/2012CN101484579B High-affinity antagonists of elr-cxc chemokines
02/28/2012US8124747 Novel hepatitis C viral sequences for use as tool in detection, treatment and prevention of viral infection; immunotherapy; immunodiagnostics
02/28/2012US8124398 Recombinant flavivirus vaccines
02/28/2012US8124397 Inactivating pathogens with oxidizing agents for vaccine production
02/28/2012US8124355 Detection and identification of groups of bacteria
02/28/2012US8124106 Virus purification methods
02/28/2012US8124105 Compositions, methods and kits relating to poxvirus subunit vaccines
02/28/2012US8124100 Inactivated nodavirus vaccine
02/23/2012WO2012024351A2 Adenoviral assembly method
02/23/2012WO2012022496A2 Method for killing tumor stem cells
02/23/2012WO2012001075A3 Immortalized avian cell lines
02/23/2012US20120046340 Down Regulation of the Gene Expression by Means of Nucleic Acid-Loaded Virus-Like Particles
02/23/2012US20120045819 Binding molecules for human factor viii and factor viii-like proteins
02/23/2012US20120045471 Recombinant parainfluenza virus vaccine comprising heterologous antigens derived from respiratory syncytial virus
02/23/2012US20120045468 Immunogenic Compositions and Uses Thereof
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012CA2808389A1 Adenoviral assembly method
02/22/2012EP2420247A1 Adenovirus formulations
02/22/2012EP2419143A1 Hpv particles and uses thereof
02/22/2012CN1688702B 表达rna病毒抗原表位的重组麻疹病毒在制备疫苗组合物中的用途 Expression rna viral epitopes in the preparation of a recombinant measles virus vaccine composition of use
02/22/2012CN102361977A Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same
02/22/2012CN102356817A Preparation of two lytic vibrio harveyi bacteriophage preparations, and application thereof
02/22/2012CN101955916B 一种宽宿主谱李斯特菌噬菌体及其制备方法和应用 One kind of broad host spectrum of Listeria bacteriophage preparation method and application
02/22/2012CN101496527B 一种弱病毒防治矮牵牛病毒病的方法 A method for controlling a weak virus petunia virus disease
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 267